Showing 1 - 18 results of 18 for search 'Dexin Kong', query time: 0.05s
Refine Results
-
1
Impedance Force Control of Manipulator Based on Variable Universe Fuzzy Control by Dexin Kong, Qingjiu Huang
Published 2023-07-01
Article -
2
Discovery of Novel PI3Kδ Inhibitors Based on the p110δ Crystal Structure by Wenqing Jia, Shuyu Luo, Wennan Zhao, Weiren Xu, Yuxu Zhong, Dexin Kong
Published 2022-09-01
Article -
3
-
4
Influenza H7N9 Virus Hemagglutinin with T169A Mutation Possesses Enhanced Thermostability and Provides Effective Immune Protection against Lethal H7N9 Virus Challenge in Chickens by Taoran Chen, Dexin Kong, Xiaolong Hu, Yinze Gao, Shaorong Lin, Ming Liao, Huiying Fan
Published 2023-08-01
Article -
5
Benzophenone-4 inhibition in marine diatoms: Physiological and molecular perspectives by Feifei Yang, Dexin Kong, Wenhao Liu, Dazhi Huang, Hailong Wu, Xingkai Che, Zhenyi Pan, Yongfu Li
Published 2024-10-01
Article -
6
Simultaneous suppression of PKM2 and PHGDH elicits synergistic anti-cancer effect in NSCLC by Kaixuan Wang, Hao Lu, Xinmiao Wang, Qingxia Liu, Jinxia Hu, Yao Liu, Yao Liu, Meihua Jin, Dexin Kong
Published 2023-05-01
Article -
7
A single immunization with H5N1 virus-like particle vaccine protects chickens against divergent H5N1 influenza viruses and vaccine efficacy is determined by adjuvant and dosage by Dexin Kong, Yanjuan He, Jiaxin Wang, Lanyan Chi, Xiang Ao, Hejia Ye, Weihong Qiu, Xiutong Zhu, Ming Liao, Huiying Fan
Published 2024-12-01
Article -
8
-
9
Stellettin B renders glioblastoma vulnerable to poly (ADP-ribose) polymerase inhibitors via suppressing homology-directed repair by Xin Peng, Yingying Wang, Shaolu Zhang, Zhennan Tao, Yuxiang Dai, Francois X. Claret, Moshe Elkabets, Hou-Wen Lin, Zhe-Sheng Chen, Dexin Kong
Published 2023-03-01
Article -
10
Comparative transcriptomic analyses of chlorogenic acid and luteolosides biosynthesis pathways at different flowering stages of diploid and tetraploid Lonicera japonica by Hongli Wang, Yanqun Li, Sibo Wang, Dexin Kong, Sunil Kumar Sahu, Mei Bai, Haoyuan Li, Linzhou Li, Yan Xu, Hongping Liang, Huan Liu, Hong Wu
Published 2020-03-01
Article -
11
Discovery of a Novel Ubenimex Derivative as a First-in-Class Dual CD13/Proteasome Inhibitor for the Treatment of Cancer by Jian Zhang, Simin Sun, Jinyu Liu, Liang Zhang, Di Guo, Naixin Zhang, Jun Zhao, Dexin Kong, Tongqiang Xu, Xuejian Wang, Wenfang Xu, Xiaoyang Li, Yuqi Jiang
Published 2023-08-01
Article -
12
SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis by Wennan Zhao, Xue Wang, Lifeng Han, Chunze Zhang, Chenxi Wang, Dexin Kong, Mingzhe Zhang, Tong Xu, Gen Li, Ge Hu, Jiahua Luo, Sook Wah Yee, Jia Yang, Andreas Stahl, Xin Chen, Youcai Zhang
Published 2024-08-01
Article -
13
Dual inhibition of HERs and PD-1 counteract resistance in KRASG12C-mutant head and neck cancer by Ofra Novoplansky, Sankar Jagadeeshan, Manu Prasad, Ksenia M. Yegodayev, Divyasree Marripati, Raghda Abu Shareb, Yariv Greenshpan, Sooraj Mathukkada, Talal Ben-Lulu, Baisali Bhattacharya, Angel Porgador, Dexin Kong, Johannes Brägelmann, J. Silvio Gutkind, Moshe Elkabets
Published 2024-11-01
Article -
14
Stellettin B Sensitizes Glioblastoma to DNA‐Damaging Treatments by Suppressing PI3K‐Mediated Homologous Recombination Repair by Xin Peng, Shaolu Zhang, Yingying Wang, Zhicheng Zhou, Zixiang Yu, Zhenxing Zhong, Liang Zhang, Zhe‐Sheng Chen, Francois X. Claret, Moshe Elkabets, Feng Wang, Fan Sun, Ran Wang, Han Liang, Hou‐Wen Lin, Dexin Kong
Published 2023-01-01
Article -
15
A novel pan-PI3K inhibitor KTC1101 synergizes with anti-PD-1 therapy by targeting tumor suppression and immune activation by Xin Peng, Xin Huang, Talal Ben Lulu, Wenqing Jia, Shaolu Zhang, Limor Cohen, Shengfan Huang, Jindian Fan, Xi Chen, Shanshan Liu, Yongzhe Wang, Kailin Wang, Sho Isoyama, Shingo Dan, Feng Wang, Zhe Zhang, Moshe Elkabets, Dexin Kong
Published 2024-03-01
Article -
16
Sequential Inhibition of PARP and BET as a Rational Therapeutic Strategy for Glioblastoma by Xin Peng, Xin Huang, Shaolu Zhang, Naixin Zhang, Shengfan Huang, Yingying Wang, Zhenxing Zhong, Shan Zhu, Haiwang Gao, Zixiang Yu, Xiaotong Yan, Zhennan Tao, Yuxiang Dai, Zhe Zhang, Xi Chen, Feng Wang, Francois X. Claret, Moshe Elkabets, Ning Ji, Yuxu Zhong, Dexin Kong
Published 2024-08-01
Article -
17
Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer by Ofra Novoplansky, Avital B. Shnerb, Divyasree Marripati, Sankar Jagadeeshan, Raghda Abu Shareb, Cristina Conde‐López, Jonathan Zorea, Manu Prasad, Talal Ben Lulu, Ksenia M. Yegodayev, Chen Benafsha, Yushi Li, Dexin Kong, Fengshen Kuo, Luc G. T. Morris, Ina Kurth, Jochen Hess, Moshe Elkabets
Published 2023-12-01
Article -
18
MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer by Barak Rotblat, Andreas Mock, Jerome Fayette, Limor Cohen, Idan Cohen, Elena Voronov, Jebrane Bouaoud, Lucas Michon, Pierre Saintigny, Luc G T Morris, Manu Prasad, Jonathan Zorea, Sankar Jagadeeshan, Avital B Shnerb, Sooraj Mathukkada, Ofra Novoplansky, Mai Badarni, Ksenia M Yegodayev, Sapir Tzadok, Libor Brezina, Andy Karabajakian, Tomer Cooks, Irit Allon, Orr Dimitstein, Benzion Joshua, Dexin Kong, Maurizio Scaltriti, Yaron Carmi, Cristina Conde-Lopez, Jochen Hess, Ina Kurth, Moshe Elkabets
Published 2022-03-01
Article